Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
Crossref DOI link: https://doi.org/10.1007/s13555-017-0201-6
Published Online: 2017-09-20
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kuznik, Andreas
Bégo-Le-Bagousse, Gaëlle
Eckert, Laurent
Gadkari, Abhijit
Simpson, Eric
Graham, Christopher N.
Miles, LaStella
Mastey, Vera
Mahajan, Puneet
Sullivan, Sean D.
Funding for this research was provided by:
Sanofi
Regeneron Pharmaceuticals Inc